Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Zachary M. Thomas"'
Publikováno v:
International Journal of Sports Physical Therapy, Vol 19, Iss 12 (2024)
# Background Anterior cruciate ligament (ACL) injury and reinjury rates are on the rise, despite improved surgical techniques and prevention programs. ACL injuries also lead to a variety of neuroplastic and neuromuscular alterations. Emerging resear
Externí odkaz:
https://doaj.org/article/293c74267a7144fc98dc87ba0603b517
Publikováno v:
International Journal of Sports Physical Therapy, Vol 19, Iss 11 (2024)
Anterior cruciate ligament (ACL) injury rates are on the rise, despite improved surgical techniques and prevention programs. While traditional rehabilitation emphasizes the restoration of motion, strength, and physical performance, emerging research
Externí odkaz:
https://doaj.org/article/427e1064c39048edbd758595e199f6c2
Autor:
Kevin E Wilk, Zachary M Thomas, Christopher A. Arrigo, Ashley M Campbell, Amir Shahien, Jeffrey R Dugas
Publikováno v:
International Journal of Sports Physical Therapy, Vol 17, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/aa09da9f69864f5d9a73354a3c799ad1
Publikováno v:
International Journal of Sports Physical Therapy. 18
The incidence of knee injuries in sport, particularly involving the ACL, appears to be increasing yearly, especially in younger age athletes. Even more concerning is the frequency of ACL reinjury also appears to be increasing year after year. Improvi
Autor:
Luis Hortells, Jeffery D. Molkentin, Evan C Meyer, Ronald J. Vagnozzi, Emma J Agnew, Iñigo Valiente-Alandi, Allen J. York, Katherine E. Yutzey, Zachary M. Thomas, Dan J Schnell
Publikováno v:
Proc Natl Acad Sci U S A
During the postnatal period in mammals, the cardiac muscle transitions from hyperplasic to hypertrophic growth, the extracellular matrix (ECM) undergoes remodeling, and the heart loses regenerative capacity. While ECM maturation and crosstalk between
Autor:
Komal Jhaveri, Joyce O’Shaughnessy, Fabrice Andre, Matthew P. Goetz, Nadia Harbeck, Miguel Martín, Francois-Clement Bidard, Zachary M. Thomas, Suzanne Young, Roohi Ismail-Khan, Lillian M. Smyth, Michael Gnant
Publikováno v:
Cancer Research. 83:OT1-01
Background: Adjuvant ET has been the standard of care for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) EBC. A significant proportion of patients with increased risk still experience disease
Publikováno v:
J Mol Cell Cardiol
Background The intracardiac nervous system (ICNS) is composed of neurons, in association with Schwann cells (SC) and endoneurial cardiac fibroblasts (ECF). Besides heart rhythm control, recent studies have implicated cardiac nerves in postnatal cardi
Publikováno v:
Journal of the American Statistical Association. 113:1669-1683
Methods for summarizing case influence in Bayesian models take essentially two forms: (1) use common divergence measures for calculating distances between the full-data posterior and the case-deleted posterior, and (2) measure the impact of infinites
Autor:
Davis-Rodriguez Stephanie R, Zachary M. Thomas, Prasad Devarajan, Valeria Rudomanova, W. Clark Bacon, Stephanie L. K. Bowers, Burns C. Blaxall, Alex Beiersdorfer, Qing Ma
Publikováno v:
Am J Physiol Renal Physiol
Fibrosis is a common feature of chronic kidney disease; however, no clinical therapies effectively target the progression of fibrosis. Inhibition of fibronectin polymerization with the small peptide pUR4 attenuates fibrosis in the liver and heart. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba5d76f1c693c50b7ba8af8a7e097ee
https://europepmc.org/articles/PMC6620592/
https://europepmc.org/articles/PMC6620592/
Autor:
Boris Lin, Andreas Sashegyi, Benjamin Solomon, Pearl Plernjit French, Yvonne Summers, Alexander Drilon, Zachary M Thomas, Herbert H. Loong, Juergen Wolf, James Chih-Hsin Yang
Publikováno v:
Journal of Clinical Oncology. 38:3588-3588
3588 Background: Randomized trials involving agents targeting oncogene addicted tumors have greatly increased over the past decade. Whether clinical response rates can predict or correlate with efficacy measures such as progression-free survival (PFS